NO20070944L - Pellet formulering med forlenget frigjoring inneholdende pramipexol eller et farmasoytiskakseptabelt salt derav, fremgangsmate forfremstilling og anvendelse derav - Google Patents
Pellet formulering med forlenget frigjoring inneholdende pramipexol eller et farmasoytiskakseptabelt salt derav, fremgangsmate forfremstilling og anvendelse deravInfo
- Publication number
- NO20070944L NO20070944L NO20070944A NO20070944A NO20070944L NO 20070944 L NO20070944 L NO 20070944L NO 20070944 A NO20070944 A NO 20070944A NO 20070944 A NO20070944 A NO 20070944A NO 20070944 L NO20070944 L NO 20070944L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutically acceptable
- extended release
- preparation
- acceptable salt
- formulation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En pelletformulering med forlenget frigjøring som omfatter et virkestoff valgt fra pramipexol og farmasøytisk akseptable salter derav, og minst ett frigjøringsmodifiserende hjelpestoff.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04019249 | 2004-08-13 | ||
PCT/EP2005/053609 WO2006015943A2 (en) | 2004-08-13 | 2005-07-25 | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070944L true NO20070944L (no) | 2007-04-27 |
Family
ID=34926162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070944A NO20070944L (no) | 2004-08-13 | 2007-02-19 | Pellet formulering med forlenget frigjoring inneholdende pramipexol eller et farmasoytiskakseptabelt salt derav, fremgangsmate forfremstilling og anvendelse derav |
Country Status (20)
Country | Link |
---|---|
US (3) | US20060051419A1 (no) |
EP (3) | EP1778201B1 (no) |
JP (1) | JP4971159B2 (no) |
KR (2) | KR20130003040A (no) |
CN (3) | CN101849920A (no) |
AU (1) | AU2005271193B2 (no) |
BR (1) | BRPI0513848A (no) |
CA (1) | CA2576386A1 (no) |
EA (2) | EA200700388A1 (no) |
EC (1) | ECSP077243A (no) |
EG (1) | EG26209A (no) |
HK (1) | HK1107780A1 (no) |
IL (1) | IL181281A0 (no) |
MX (1) | MX2007001850A (no) |
NO (1) | NO20070944L (no) |
NZ (1) | NZ553645A (no) |
SG (1) | SG164375A1 (no) |
UA (3) | UA88477C2 (no) |
WO (1) | WO2006015943A2 (no) |
ZA (1) | ZA200700313B (no) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157480B2 (en) * | 2001-12-11 | 2007-01-02 | University Of Virginia Patent Foundation | Use of pramipexole to treat amyotrophic lateral sclerosis |
US20060281797A1 (en) * | 2001-12-11 | 2006-12-14 | University Of Virginia Patent Foundation | Neurorestoration with R(+) Pramipexole |
MY142204A (en) * | 2002-07-25 | 2010-10-29 | Pharmacia Corp | Pramipexole once-daily dosage form |
US20050226926A1 (en) | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
PL1789021T3 (pl) * | 2004-08-13 | 2012-04-30 | Boehringer Ingelheim Int | Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól |
CA2576386A1 (en) | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
WO2006046256A1 (en) * | 2004-10-27 | 2006-05-04 | Alembic Limited | Extended release formulation of pramipexole dihydrochloride |
WO2007002518A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Delayed release or extended-delayed release dosage forms of pramipexole |
US20070148238A1 (en) * | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
JP2009504748A (ja) * | 2005-08-15 | 2009-02-05 | ユニバーシティ オブ バージニア パテント ファウンデーション | R(+)プラミペキソールを用いた神経回復 |
WO2007090882A2 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical extended release compositions comprising pramipexole |
US20090041844A1 (en) * | 2006-02-10 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Modified Release Formulation |
US20090098202A1 (en) * | 2006-02-10 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Extended Release Formulation |
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
US20070259930A1 (en) * | 2006-04-10 | 2007-11-08 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
EP2010158B1 (en) * | 2006-04-26 | 2016-02-17 | Alphapharm Pty Ltd. | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
CA2651798C (en) * | 2006-05-09 | 2015-07-21 | Mallinckrodt Inc. | Zero-order modified release solid dosage forms |
ES2379117T3 (es) | 2006-05-16 | 2012-04-20 | Knopp Neurosciences, Inc. | Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas |
EP2465500A1 (en) * | 2006-05-16 | 2012-06-20 | Knopp Neurosciences, Inc. | Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of parkinson's disease |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
BRPI0715835A2 (pt) * | 2006-08-24 | 2013-07-23 | Boehringer Ingelheim Pharma | processo para preparar comprimidos de dicloridrato de pramipexol |
WO2008062446A2 (en) * | 2006-09-14 | 2008-05-29 | Alembic Limited | An extended release composition of levetiracetam, which exhibits no adverse food effect |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
AU2007338631A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
JP2010521496A (ja) * | 2007-03-14 | 2010-06-24 | ノップ ニューロサイエンシーズ、インク. | キラル精製置換ベンゾチアゾールジアミンの合成 |
CN101677564A (zh) * | 2007-03-14 | 2010-03-24 | 诺普神经科学股份有限公司 | (6r)-4,5,6,7-四氢-n6-丙基-2,6-苯并噻唑-二胺的改良释放制剂及其使用方法 |
EP2150239A1 (en) * | 2007-04-24 | 2010-02-10 | Boehringer Ingelheim International GmbH | Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
US20110190356A1 (en) * | 2008-08-19 | 2011-08-04 | Knopp Neurosciences Inc. | Compositions and Methods of Using (R)- Pramipexole |
US20120021057A1 (en) * | 2009-04-09 | 2012-01-26 | Purdue Pharma | Once-daily oral ir/cr pramipexole formulation |
WO2010148409A1 (en) * | 2009-06-19 | 2010-12-23 | Knopp Neurosciences, Inc. | Compositions and methods for treating amyotrophic lateral sclerosis |
WO2011128914A2 (en) * | 2010-04-15 | 2011-10-20 | Cadila Healthcare Limited | Extended release pharmaceutical compositions of pramipexole |
EP2380560A1 (de) * | 2010-04-22 | 2011-10-26 | ratiopharm GmbH | Pramipexol enthaltende Matrixtablette |
WO2011148243A1 (en) * | 2010-05-24 | 2011-12-01 | Lupin Limited | Extended release formulation of pramipexole |
KR101307334B1 (ko) * | 2010-07-02 | 2013-09-12 | 주식회사 바이오파마티스 | 프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물 |
EP2462925A1 (en) * | 2010-11-12 | 2012-06-13 | Neuraxpharm Arzneimittel GmbH | Pramipexole Dihydrochloride Granulate |
EA027817B1 (ru) | 2011-03-21 | 2017-09-29 | Бёрингер Ингельхайм Интернациональ Гмбх | Лекарственная форма, содержащая твёрдую амброксолсодержащую композицию, и ее применение |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
KR101659983B1 (ko) * | 2012-12-31 | 2016-09-26 | 주식회사 삼양바이오팜 | 용융 압출된 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제 |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
LT3019167T (lt) | 2013-07-12 | 2021-03-25 | Knopp Biosciences Llc | Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
AU2014306597B2 (en) | 2013-08-13 | 2018-05-17 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
EP3038467B1 (en) | 2013-08-13 | 2020-07-29 | Knopp Biosciences LLC | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
CN104367562A (zh) * | 2013-08-15 | 2015-02-25 | 上海星泰医药科技有限公司 | 盐酸普拉克索缓释片及制备方法 |
ITMI20132066A1 (it) * | 2013-12-11 | 2015-06-12 | Farmatron Ltd | Sistemi terapeutici a rilascio modificato per la somministrazione orale di mentolo nel trattamento delle malattie intestinali |
CN105456216B (zh) * | 2014-08-18 | 2019-11-05 | 江苏神龙药业股份有限公司 | 盐酸普拉克索缓释片剂组合物及其制备方法 |
EP3922242A1 (en) | 2014-09-15 | 2021-12-15 | Orphazyme A/S | Arimoclomol formulation |
CN104367565A (zh) * | 2014-11-21 | 2015-02-25 | 哈尔滨圣吉药业股份有限公司 | 一种盐酸普拉克索缓释微丸 |
CN104606162B (zh) * | 2015-01-07 | 2017-03-29 | 海南康虹医药科技开发有限公司 | 一种盐酸普拉克索缓释制剂及其制备方法 |
CN104784155B (zh) * | 2015-05-15 | 2018-02-23 | 中国药科大学 | 一种盐酸普拉克索组合微丸胶囊及其制备方法 |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2887440A (en) * | 1957-08-12 | 1959-05-19 | Dow Chemical Co | Enteric coating |
US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
NL265428A (no) * | 1960-06-06 | |||
US3458622A (en) * | 1967-04-07 | 1969-07-29 | Squibb & Sons Inc | Controlled release tablet |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
JPS58403B2 (ja) * | 1975-07-24 | 1983-01-06 | 武田薬品工業株式会社 | L− アスコルビンサンセイザイノ セイゾウホウ |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
CH649215A5 (de) | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
US4424235A (en) * | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
EP0186087B1 (de) * | 1984-12-22 | 1989-08-23 | Dr. Karl Thomae GmbH | Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel |
US4738851A (en) * | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
US4666612A (en) * | 1986-03-17 | 1987-05-19 | Kerr-Mcgee Chemical Corporation | Method for recovering a wood preservative from waste sludges |
US4772473A (en) | 1986-06-16 | 1988-09-20 | Norwich Eaton Pharmaceuticals, Inc. | Nitrofurantoin dosage form |
US4709712A (en) * | 1986-10-22 | 1987-12-01 | Dermatalogical Products Of Texas | Polycarboxylic acid polymer gels as protective agents |
US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
US4789549A (en) * | 1987-03-09 | 1988-12-06 | Warner-Lambert Company | Sustained release dosage forms |
US4859470A (en) | 1988-06-02 | 1989-08-22 | Alza Corporation | Dosage form for delivering diltiazem |
GB8828020D0 (en) * | 1988-12-01 | 1989-01-05 | Unilever Plc | Topical composition |
US5026559A (en) * | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
US5007790A (en) * | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
JP2955358B2 (ja) | 1989-06-09 | 1999-10-04 | ファルマシア・アンド・アップジョン・カンパニー | 中枢神経系活性を有する複素環系アミン |
US5273975A (en) * | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
JP2813809B2 (ja) * | 1989-06-19 | 1998-10-22 | 武田薬品工業株式会社 | 有核顆粒製剤およびその製造法 |
FR2653337B1 (fr) | 1989-10-23 | 1992-02-07 | Dow Corning Sa | Element a liberation prolongee et procede pour le fabriquer. |
IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
JPH04234812A (ja) * | 1990-03-16 | 1992-08-24 | Yamanouchi Pharmaceut Co Ltd | 持続性製剤用顆粒 |
GB9015822D0 (en) | 1990-07-18 | 1990-09-05 | Beecham Group Plc | Compositions |
US5681585A (en) * | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5656296A (en) * | 1992-04-29 | 1997-08-12 | Warner-Lambert Company | Dual control sustained release drug delivery systems and methods for preparing same |
US5731338A (en) * | 1992-07-02 | 1998-03-24 | Oramed, Inc. | Controlled release pilocarpine delivery system |
RO112991B1 (ro) | 1992-09-18 | 1998-03-30 | Yamanouchi Pharma Co Ltd | Preparat tip hidrogel, cu eliberare sustinuta |
DE4241013A1 (de) * | 1992-12-05 | 1994-06-09 | Boehringer Ingelheim Kg | Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
US5458887A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
JPH07330606A (ja) * | 1994-06-08 | 1995-12-19 | Towa Yakuhin Kk | ニカルジピン持続性製剤用顆粒 |
US5650420A (en) | 1994-12-15 | 1997-07-22 | Pharmacia & Upjohn Company | Pramipexole as a neuroprotective agent |
EA000818B1 (ru) | 1995-12-27 | 2000-04-24 | Жансен Фармасетика Н.В. | Биоадгезивная твердая дозированная лекарственная форма |
US5846971A (en) * | 1996-06-28 | 1998-12-08 | Schering Corporation | Oral antifungal composition |
GB9619074D0 (en) * | 1996-09-12 | 1996-10-23 | Smithkline Beecham Plc | Composition |
JP4083818B2 (ja) * | 1997-06-06 | 2008-04-30 | ディポメド,インコーポレイティド | 高度可溶性薬物の制御された放出のための胃滞留性の経口薬物投与形 |
JP3739410B2 (ja) | 1997-07-02 | 2006-01-25 | ユーロ−セルティーク エス.エイ. | 安定化された徐放性トラマドール製剤 |
US5895663A (en) | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
US6248358B1 (en) * | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
US6624200B2 (en) * | 1998-08-25 | 2003-09-23 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
DE69819748T2 (de) * | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
ATE239447T1 (de) | 1997-09-29 | 2003-05-15 | Inhale Therapeutic Syst | In verneblern verwendbare, stabilisierte zubereitungen |
US6197339B1 (en) * | 1997-09-30 | 2001-03-06 | Pharmacia & Upjohn Company | Sustained release tablet formulation to treat Parkinson's disease |
US6056977A (en) * | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
US20020013304A1 (en) | 1997-10-28 | 2002-01-31 | Wilson Leland F. | As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
US20020054911A1 (en) * | 2000-05-11 | 2002-05-09 | Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi | Novel oral dosage form for carvedilol |
GB9802201D0 (en) | 1998-02-03 | 1998-04-01 | Cerestar Holding Bv | Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules |
AU748396C (en) * | 1998-03-11 | 2003-01-23 | Smithkline Beecham Corporation | Composition |
DK1076559T3 (da) | 1998-05-15 | 2006-01-16 | Pharmacia & Upjohn Co Llc | Cabergolin og pramipexol til behandling af CNS-sygdomme især Parkinson's sygdom |
GB9812426D0 (en) | 1998-06-10 | 1998-08-05 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
US6312728B1 (en) * | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
TW407058B (en) * | 1998-07-17 | 2000-10-01 | Dev Center Biotechnology | Oral cisapride dosage forms with an extended duration |
US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
US6270805B1 (en) | 1998-11-06 | 2001-08-07 | Andrx Pharmaceuticals, Inc. | Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
CA2371940C (en) * | 1999-03-31 | 2008-07-15 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
DE19927688A1 (de) * | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
US6417177B1 (en) * | 1999-07-13 | 2002-07-09 | Alpha Research Group, Llc | Chloroquine derivatives for the treatment of Parkinson's disease |
GB9923045D0 (en) | 1999-09-29 | 1999-12-01 | Novartis Ag | New oral formulations |
JP2003512311A (ja) | 1999-10-19 | 2003-04-02 | エヌピーエス ファーマシューティカルズ インコーポレーテッド | Cns介在性障害を治療するための持続放出製剤 |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
MXPA02006150A (es) * | 1999-12-22 | 2004-09-06 | Pharmacia Corp | Formulaciones de liberacion sostenida de un inhibidor de ciclooxigenasa-2. |
US6467637B2 (en) * | 2000-01-27 | 2002-10-22 | The York Group, Inc. | Death care merchandising system |
EP2517710B1 (en) * | 2000-02-08 | 2015-03-25 | Euro-Celtique S.A. | Tamper-resistant oral opioid agonist formulations |
PE20011074A1 (es) * | 2000-02-23 | 2001-10-04 | Upjohn Co | Uso de pramipexol en el tratamiento de trastornos de adiccion |
CN1660435A (zh) * | 2000-02-24 | 2005-08-31 | 法玛西雅厄普约翰美国公司 | 新的药物联合形式 |
US6955821B2 (en) * | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US6277875B1 (en) * | 2000-07-17 | 2001-08-21 | Andrew J. Holman | Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
CA2418915A1 (en) * | 2000-08-08 | 2002-02-14 | Teva Pharmaceutical Industries Ltd. | Stable pergolide mesylate and process for making same |
ES2187249B1 (es) * | 2000-09-18 | 2004-09-16 | Synthon Bv | Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles. |
SE0004671D0 (sv) * | 2000-12-15 | 2000-12-15 | Amarin Dev Ab | Pharmaceutical formulation |
EP1411901B1 (en) | 2001-07-04 | 2010-08-18 | Sun Pharma Advanced Research Company Ltd | Gastric retention controlled drug delivery system |
US20030022875A1 (en) | 2001-07-27 | 2003-01-30 | Wilson Leland F. | As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
US20030032661A1 (en) * | 2001-08-02 | 2003-02-13 | Boehringer Ingelheim Pharma Kg | Pramipexole as an anticonvulsant |
DE10138275A1 (de) | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
GB0125088D0 (en) | 2001-10-18 | 2001-12-12 | Smithkline Beecham Cork Ltd | New use |
US20030133982A1 (en) * | 2001-12-20 | 2003-07-17 | Heimlich John M. | Zero-order sustained release dosage forms and method of making same |
ATE432689T1 (de) | 2002-03-04 | 2009-06-15 | Ipsen Pharma | Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid |
DK2425824T5 (en) * | 2002-04-05 | 2018-02-12 | Mundipharma As | Pharmaceutical preparation containing oxycodone and naloxone |
US20030215498A1 (en) * | 2002-05-17 | 2003-11-20 | Harland Ronald S. | Rapidly disintegrating comressed tablets comprising biologically active compounds |
BR0312206A (pt) * | 2002-06-27 | 2005-04-12 | Cilag Ag | Formulações de pélete esférico |
JP4478413B2 (ja) | 2002-07-11 | 2010-06-09 | 武田薬品工業株式会社 | 被覆製剤の製造法 |
US20070196481A1 (en) * | 2002-07-25 | 2007-08-23 | Amidon Gregory E | Sustained-release tablet composition |
BR0312876A (pt) * | 2002-07-25 | 2005-06-28 | Pharmacia Corp | Método de preparação de formas de dosagem sólidas revestidas em duas camadas compreendendo um polìmero insolúvel em água e um agente formador de poros solúvel em água |
MY142204A (en) * | 2002-07-25 | 2010-10-29 | Pharmacia Corp | Pramipexole once-daily dosage form |
US20050226926A1 (en) * | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
AU2002361495A1 (en) | 2002-12-24 | 2004-07-22 | Lupin Limited | Enteric coated fluoxetine composition |
CA2415154C (en) | 2002-12-24 | 2009-06-16 | Biovail Laboratories Inc. | Modified release formulations of selective serotonin re-uptake inhibitors |
WO2004080440A1 (en) | 2003-03-11 | 2004-09-23 | Korea United Pharm, Inc. | Process for the preparing of hardcapsule formulation containing lansoprazole |
BRPI0408999A (pt) * | 2003-04-04 | 2006-03-28 | Pharmacia Corp | comprimidos prensados de multiparticulados de liberação oral prolongada |
US20050020589A1 (en) * | 2003-06-18 | 2005-01-27 | Pfizer Inc. | Sustained-release tablet composition comprising a dopamine receptor agonist |
CA2576386A1 (en) * | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
PL1789021T3 (pl) * | 2004-08-13 | 2012-04-30 | Boehringer Ingelheim Int | Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól |
WO2006046256A1 (en) | 2004-10-27 | 2006-05-04 | Alembic Limited | Extended release formulation of pramipexole dihydrochloride |
WO2007002518A1 (en) | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Delayed release or extended-delayed release dosage forms of pramipexole |
US20070148238A1 (en) | 2005-06-23 | 2007-06-28 | Spherics, Inc. | Dosage forms for movement disorder treatment |
JP2009504748A (ja) | 2005-08-15 | 2009-02-05 | ユニバーシティ オブ バージニア パテント ファウンデーション | R(+)プラミペキソールを用いた神経回復 |
WO2007054976A2 (en) | 2005-11-08 | 2007-05-18 | Panacea Biotec Ltd. | Lipid based controlled release pharmaceutical composition |
WO2007090882A2 (en) | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical extended release compositions comprising pramipexole |
US20090098202A1 (en) * | 2006-02-10 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Extended Release Formulation |
US20090041844A1 (en) * | 2006-02-10 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Modified Release Formulation |
EP1886665A1 (en) * | 2006-08-01 | 2008-02-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Gastro retentive delivery system |
CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
AR062321A1 (es) * | 2006-08-25 | 2008-10-29 | Boehringer Ingelheim Int | Sistema de liberacion controlada y metodo para fabricarlo |
-
2005
- 2005-07-25 CA CA002576386A patent/CA2576386A1/en not_active Abandoned
- 2005-07-25 EP EP05769893.8A patent/EP1778201B1/en active Active
- 2005-07-25 JP JP2007525279A patent/JP4971159B2/ja not_active Expired - Fee Related
- 2005-07-25 AU AU2005271193A patent/AU2005271193B2/en not_active Ceased
- 2005-07-25 SG SG201005244-7A patent/SG164375A1/en unknown
- 2005-07-25 CN CN201010196130A patent/CN101849920A/zh active Pending
- 2005-07-25 KR KR1020127033319A patent/KR20130003040A/ko active IP Right Grant
- 2005-07-25 EP EP11190711A patent/EP2431027A1/en not_active Withdrawn
- 2005-07-25 EA EA200700388A patent/EA200700388A1/ru unknown
- 2005-07-25 KR KR1020077005743A patent/KR20070050081A/ko active IP Right Grant
- 2005-07-25 EP EP11190708A patent/EP2431026A1/en not_active Withdrawn
- 2005-07-25 UA UAA200702473A patent/UA88477C2/ru unknown
- 2005-07-25 MX MX2007001850A patent/MX2007001850A/es active IP Right Grant
- 2005-07-25 CN CN2005800275003A patent/CN101022788B/zh not_active Expired - Fee Related
- 2005-07-25 BR BRPI0513848-5A patent/BRPI0513848A/pt not_active IP Right Cessation
- 2005-07-25 NZ NZ553645A patent/NZ553645A/en not_active IP Right Cessation
- 2005-07-25 WO PCT/EP2005/053609 patent/WO2006015943A2/en active Application Filing
- 2005-07-25 CN CN201010198667A patent/CN101843597A/zh active Pending
- 2005-07-25 EA EA201001086A patent/EA201001086A1/ru unknown
- 2005-07-25 UA UAA200906587A patent/UA95993C2/ru unknown
- 2005-07-25 UA UAA201010396A patent/UA97084C2/ru unknown
- 2005-08-12 US US11/202,689 patent/US20060051419A1/en not_active Abandoned
-
2007
- 2007-01-11 ZA ZA200700313A patent/ZA200700313B/xx unknown
- 2007-02-11 EG EGPCTNA2007000148A patent/EG26209A/en active
- 2007-02-12 IL IL181281A patent/IL181281A0/en unknown
- 2007-02-13 EC EC2007007243A patent/ECSP077243A/es unknown
- 2007-02-19 NO NO20070944A patent/NO20070944L/no not_active Application Discontinuation
-
2008
- 2008-02-14 HK HK08101608.4A patent/HK1107780A1/xx unknown
- 2008-11-24 US US12/276,610 patent/US20090130197A1/en not_active Abandoned
-
2009
- 2009-12-03 US US12/630,271 patent/US8715728B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070944L (no) | Pellet formulering med forlenget frigjoring inneholdende pramipexol eller et farmasoytiskakseptabelt salt derav, fremgangsmate forfremstilling og anvendelse derav | |
DK1781260T4 (da) | Tabletformulering med forlænget frigivelse indeholdende pramipexol eller et farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
WO2006025070A3 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol | |
NO20063322L (no) | Morfolinylinneholdende benzimidazoler som inhibitorer av respiratorisk syncytialvirusreplikasjon | |
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
RU2011138962A (ru) | Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1 | |
NO20072939L (no) | Makroloner - aminosubstituerte kinoloner | |
NO20064297L (no) | Aminoalkoholforbindelse | |
NO20082265L (no) | Dispergerbare tabletter som innbefatter deferasirox | |
NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
NO20054848L (no) | Substituerte p-diaminobenzenderivater | |
WO2003072025A3 (en) | Modified release formulations of at least one form of tramadol | |
NO20082643L (no) | Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft | |
NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
NO20075920L (no) | Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria | |
NO20082938L (no) | Formuleringer av quinolinoner | |
NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
DK1791537T3 (da) | 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase | |
NO20080110L (no) | Benzimidazolderivativer som 5-HT6,5-HT24 | |
WO2005105778A3 (en) | 4-amino-5-cyanopyrimidine derivatives | |
NO20083183L (no) | Fast farmasoytisk sammensetning inneholdende irbesartan | |
EP2077111A4 (en) | ANTIDEPRESSANT AGENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |